A carregar...
International variability in the reimbursement of cancer drugs by publically funded drug programs
PURPOSE: Evaluate inter-country variability in the reimbursement of publically funded cancer drugs, and identify factors such as cost containment measures that may contribute to variability. METHODS: As of February 28, 2010, licensed indications for 10 cancer drugs (bevacizumab, bortezomib, cetuxima...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3364777/ https://ncbi.nlm.nih.gov/pubmed/22670106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.946 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|